Performa Ltd (US)’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,250
Closed -$9.2K 49
2025
Q4
$9.2K Buy
+3,250
New +$16.8K ﹤0.01% 28
2025
Q3
Sell
-250
Closed -$1.48K 56
2025
Q2
$1.48K Sell
250
-350
-58% -$2.01K ﹤0.01% 50
2025
Q1
$3.83K Buy
+600
New +$5.79K ﹤0.01% 44
2023
Q4
Sell
-273
Closed -$2.35K 52
2023
Q3
$2.35K Sell
273
-177
-39% -$1.26K ﹤0.01% 64
2023
Q2
$3.55K Sell
450
-400
-47% -$2.78K ﹤0.01% 62
2023
Q1
$6.33K Buy
+850
New +$8.45K ﹤0.01% 47

Other funds holding ASPN

Performa Ltd (US)'s ASPN Position: Q1 2026 in Review

Performa Ltd (US) sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 3,250 shares — an estimated $9.2K sold.

Performa Ltd (US) first reported a position in ASPN in Q1 2023 and held it in 6 quarters. The position peaked at $9.2K in Q4 2025. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Performa Ltd (US) reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Performa Ltd (US) sold 3,250 Aspen Aerogels shares in Q1 2026, an estimated $9.2K.
  • Performa Ltd (US) first reported a position in Aspen Aerogels in Q1 2023 and held it in 6 quarters.
  • Performa Ltd (US)'s Aspen Aerogels position peaked at $9.2K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Performa Ltd (US)'s 13F filing for Q1 2026, filed 6 May 2026.